Preventing heart disease requires a universal approach
Preventive cardiology is now on the political as well as clinical agenda. In 2011 a UN heads-of-state meeting agreed to reduce mortality from chronic non-communicable diseases (NCDs) by 25% by 2025.
The facts (and the social pressure) before the politicians were unequivocal:
- Cardiovascular diseases account for most NCD deaths in the world, or 17 million people annually - followed by cancers (7.6 million), respiratory diseases (4.2 million), and diabetes (1.3 million).
- These four groups of diseases account for around 80% of all NCD deaths.
- They share four risk factors: tobacco use, physical inactivity, the harmful use of alcohol and unhealthy diets.
This year's EuroPRevent congress, already the world's leading forum for the presentation of new research in preventive cardiology, has adopted as its theme the Universal Approach to Preventive Cardiology and includes in the scientific programme sessions on how to achieve the UN's target of a 25% mortality reduction by 2025. Professor Volker Adams, Chairperson of the Congress Programme Committee highlights that "as is now increasingly recognised and as this congress will reflect, the prevention of CVD cannot be achieved by cardiologists alone. A team approach is needed including exercise physiologists, nutritionists, psychologists and governments. Prevention networks will be an important feature at EuroPRevent."
Among the congress's sessions are two conventions of the Global Forum on CVD Prevention in Clinical Practice, in which national and international associations outline their strategies to achieve NCD mortality targets. "Key messages still relate to banning tobacco use, promoting healthy diets, increasing physical exercise and moderating alcohol consumption," says Professor Stephan Gielen, President of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR), the congress organisers. "CVD is preventable," he adds, "but lifestyles must change and this will only come about with a concerted effort."
Also on the congress's political agenda is a presentation on the impact of the Lazy Town TV series in the USA. The series encourages children in a fun and creative way to adopt a healthy diet and daily physical activity - and is featured here as an example of how to convey preventive messages to a young audience.
More than 550 abstracts of new scientific research in CVD prevention have been accepted for this congress, and many will provide much public health interest. The leading nations reporting new studies are Italy (the congress's host country), Russia, Spain, Germany and UK.
EuroPRevent 2013 will take place at the Palazzo dei Congressi in Rome, Italy, from 18-20 April 2013.
The event promises to be the leading event of the year in preventive cardiology and we encourage you to mark the event in your news diaries. The scientific programme contains many new reports on a subject which is traditionally of great public interest.
Building on Italy's emphasis on sports medicine, the congress will open with a Master Class on Diagnostic imaging in Sports Cardiology , highlighting its importance in prevention and rehabilitation. A screening protocol developed by the EACPR has the power to identify (or raise suspicion for) most of the cardiac disease at risk.
Other scientific sessions will highlight further emerging themes and provide new evidence in established themes, three of which will be featured in press releases issued during the congress:
- On the impact of heavy work on cardiovascular risk
- On pollution and air particle composition
- On the relative risks of smoking cessation and weight gain
More information: Further details of EuroPRevent 2013 can be found at www.escardio.org/c… welcome.aspx
Provided by
European Society of Cardiology
-
Mortality from CVD in Brazil has increased 3.5 times more than in other developing countries
Sep 14, 2012 |
not rated yet |
0
-
Global CVD leaders call the world to action—25 by 2025—from the World Congress of Cardiology
Apr 23, 2012 |
not rated yet |
0
-
Prevention is better than cure for killer cardiovascular disease
Jul 06, 2012 |
not rated yet |
0
-
Cardiovascular disease community calls for tougher targets to curb global risk
Sep 18, 2012 |
not rated yet |
0
-
Increasing cardiovascular disease in China: Urgent need for prevention
Oct 12, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Calculating on-axis elements of a solenoid
1 hour ago
-
latitude & longitude & air pressure
3 hours ago
-
Differences of Classical Mechanics when learned with Calc vs algebra?
6 hours ago
-
what is the distance traveled
10 hours ago
-
Image of a Convex Lens Cut in Half Horizontally
14 hours ago
-
Ray tracing throught optical system of thick lenses
14 hours ago
- More from Physics Forums - Classical Physics
More news stories
Costs to treat stroke in America may double by 2030
Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.
Cardiology
10 hours ago |
not rated yet |
0
New blood-thinner measures may cut medication errors
Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...
Cardiology
13 hours ago |
not rated yet |
0
Registry questions superiority of bivalirudin over heparin
Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...
Cardiology
13 hours ago |
not rated yet |
0
Study shows low rate of late lumen loss with bioresorbable DESolve device
The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial ...
Cardiology
13 hours ago |
not rated yet |
0
Biodegradable stent proves non-inferior to drug-eluting stent
The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...
Cardiology
May 21, 2013 |
5 / 5 (1) |
0
Slowing the aging process—only with antibiotics
Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.
Researchers complete largest genetic sequencing study of human disease
Researchers from Queen Mary, University of London have led the largest sequencing study of human disease to date, investigating the genetic basis of six autoimmune diseases.
Brain can be trained in compassion, study shows
Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.
Having both migraines, depression may mean smaller brain
(HealthDay)—Migraines and depression can each cause a great deal of suffering, but new research indicates the combination of the two may be linked to something else entirely—a smaller brain.
Novel approach for influenza vaccination shows promise in early animal testing
A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine ...
Enzyme-activating antibodies revealed as marker for most severe form of rheumatoid arthritis
In a series of lab experiments designed to unravel the workings of a key enzyme widely considered a possible trigger of rheumatoid arthritis, researchers at Johns Hopkins have found that in the most severe ...